These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15964743)

  • 1. Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.
    Buckley PF; Miller DD; Singer B; Arena J; Stirewalt EM
    Schizophr Res; 2005 Nov; 79(2-3):281-8. PubMed ID: 15964743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice.
    Ketter TA; Haupt DW
    Curr Med Res Opin; 2006 Dec; 22(12):2345-53. PubMed ID: 17257449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathophysiology of metabolic effects of antipsychotic medications.
    Ballon JS; Pajvani U; Freyberg Z; Leibel RL; Lieberman JA
    Trends Endocrinol Metab; 2014 Nov; 25(11):593-600. PubMed ID: 25190097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring for metabolic complications associated with atypical antipsychotics.
    Farver D
    S D J Med; 2005 Feb; 58(2):53-4. PubMed ID: 15756776
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic side effects of antipsychotic medication.
    Tschoner A; Engl J; Laimer M; Kaser S; Rettenbacher M; Fleischhacker WW; Patsch JR; Ebenbichler CF
    Int J Clin Pract; 2007 Aug; 61(8):1356-70. PubMed ID: 17627711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis.
    Mizuno Y; Suzuki T; Nakagawa A; Yoshida K; Mimura M; Fleischhacker WW; Uchida H
    Schizophr Bull; 2014 Nov; 40(6):1385-403. PubMed ID: 24636967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent metabolic effects of second-generation antipsychotics in second-generation antipsychotic-naïve French Canadian patients.
    Roy G; Bedard A; Desmarais PA; Jourdain F; Allen S; Michaud D; Ben Amor L
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):479-87. PubMed ID: 21186966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Atypical antipsychotic induced weight gain and metabolic disorders].
    Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C
    Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin to reduce weight gain and metabolic disturbance in schizophrenia.
    Faulkner G; Duncan M
    Evid Based Ment Health; 2015 Aug; 18(3):89. PubMed ID: 26081916
    [No Abstract]   [Full Text] [Related]  

  • 15. A systematic review of metabolic side effects related to the use of antipsychotic drugs in dementia.
    Atti AR; Ferrari Gozzi B; Zuliani G; Bernabei V; Scudellari P; Berardi D; De Ronchi D; Tarricone I; Menchetti M
    Int Psychogeriatr; 2014 Jan; 26(1):19-37. PubMed ID: 24103643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to counter antipsychotic-associated weight gain in patients with schizophrenia.
    Marteene W; Winckel K; Hollingworth S; Kisely S; Gallagher E; Hahn M; Ebdrup BH; Firth J; Siskind D
    Expert Opin Drug Saf; 2019 Dec; 18(12):1149-1160. PubMed ID: 31564170
    [No Abstract]   [Full Text] [Related]  

  • 17. Antipsychotic induced weight gain in schizophrenia:mechanisms and management.
    Rege S
    Aust N Z J Psychiatry; 2008 May; 42(5):369-81. PubMed ID: 18473255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents.
    Maayan L; Correll CU
    J Child Adolesc Psychopharmacol; 2011 Dec; 21(6):517-35. PubMed ID: 22166172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic monitoring for patients treated with antipsychotic medications.
    Cohn TA; Sernyak MJ
    Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring?
    Guillemot J; Laborie C; Dutriez-Casteloot I; Maron M; Deloof S; Lesage J; Breton C; Vieau D
    Eur J Pharmacol; 2011 Sep; 667(1-3):13-6. PubMed ID: 21664905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.